Please login to the form below

Not currently logged in
Email:
Password:

NICE backs two cancer drugs

National Institute for Health and Care Excellence NICE logo

Boehringer’s Giotrif and Janssen’s Velcade given final go-ahead for NHS use

Pfizer set to file Xeljanz for psoriasis

Pfizer headquartersSet to add another indication after positive study results

Valeant offers $45.7bn for Botox firm Allergan

Valeant Pharma logoTrend for major pharma deals continues

Pfizer rumoured to be after AstraZeneca

Pfizer AstraZenecaIs this the return of the pharma mega-merger?

Novartis pays $16bn for GSK's oncology portfolio

Novartis buildingSwiss company strikes series of deals, including one to step away from vaccines

EMA warns on stolen Herceptin

Roche Herceptin trastuzumab cancerSays vials of cancer drug have been tampered with and re-introduced into supply chain

Lilly's stomach cancer drug cleared by FDA

Eli Lilly HQ thumbCyramza is tipped to reach blockbuster status depending on approvals

GSK corruption claims extend to Jordan and Lebanon

GSK - logo on buildingFollows bribery allegations in Poland, China and Iraq

Reckitt Benckiser may spin out pharma division

Reckitt BenckiserMoves to focus on consumer health and household goods

Sex is a good trick

But pharma companies - and payers - should stop incestuous ‘best practice’ behaviours and look for new ways of comparing options

Latest appointments

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PAN

PAN specialises in original, enticing, aspirational and engaging digital and print solutions to maximize brand potential (www.influentialcreativity.com) `Influential creativity' is...

Latest intelligence

Online Physician Communities
Study highlights value of internet for doctors in Eastern Europe
Electronic direct mail is proving popular as online access increases...
England’s clinical commissioning landscape
Who are the real masters in the new NHS?...
How will the new landscape of Hep C treatments affect patients?
The development of new therapeutic agents is set to transform the treatment of hepatitis C over the coming years....